Skip to content

002622.SZ

皓宸医疗

SZSE · Industrials · Q 卫生 · CN

CNY 2.47
−1.59%
Ask drillr

Year over year

Reported trailing growth

Revenue
-17.4%
EBITDA
EBIT
EPS
Free cash flow
-14.0%
Operating cash flow
-0.7%

Forward estimates

Based on analyst estimates

Revenue
EBITDA
EPS

Three-year CAGR

Revenue
+12.0%
EBITDA
EBIT
Net income
EPS
Free cash flow
+74.8%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026